-
PEARL translational network: an infrastructure for person-centricity and improved clinical outcomes
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley Grill, Don Vena, Louis Terracio & Van P Thompson
Research Update: Clinical Investigation
-
PEARL translational network: an infrastructure for person-centricity and improved clinical outcomes
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley Grill, Don Vena, Louis Terracio & Van P Thompson
Research Update: Clinical Investigation
-
PEARL translational network: an infrastructure for person-centricity and improved clinical outcomes
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley Grill, Don Vena, Louis Terracio & Van P Thompson
Research Update: Clinical Investigation
-
PEARL translational network: an infrastructure for person-centricity and improved clinical outcomes
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley Grill, Don Vena, Louis Terracio & Van P Thompson
Research Update: Clinical Investigation
-
PEARL translational network: an infrastructure for person-centricity and improved clinical outcomes
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley Grill, Don Vena, Louis Terracio & Van P Thompson
Research Update: Clinical Investigation
-
PEARL translational network: an infrastructure for person-centricity and improved clinical outcomes
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley Grill, Don Vena, Louis Terracio & Van P Thompson
Research Update: Clinical Investigation
-
PEARL translational network: an infrastructure for person-centricity and improved clinical outcomes
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley Grill, Don Vena, Louis Terracio & Van P Thompson
Research Update: Clinical Investigation
-
PEARL translational network: an infrastructure for person-centricity and improved clinical outcomes
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley Grill, Don Vena, Louis Terracio & Van P Thompson
Research Update: Clinical Investigation
-
Will thrombopoietin receptor agonists become a treatment option for pediatric chronic immune thrombocytopenia in the future?
Gregory Cheng
Clinical Trail Perspective: Clinical Investigation
-
Will thrombopoietin receptor agonists become a treatment option for pediatric chronic immune thrombocytopenia in the future?
Gregory Cheng
Clinical Trail Perspective: Clinical Investigation
-
Will thrombopoietin receptor agonists become a treatment option for pediatric chronic immune thrombocytopenia in the future?
Gregory Cheng
Clinical Trail Perspective: Clinical Investigation
-
Will thrombopoietin receptor agonists become a treatment option for pediatric chronic immune thrombocytopenia in the future?
Gregory Cheng
Clinical Trail Perspective: Clinical Investigation
-
Will thrombopoietin receptor agonists become a treatment option for pediatric chronic immune thrombocytopenia in the future?
Gregory Cheng
Clinical Trail Perspective: Clinical Investigation
-
Will thrombopoietin receptor agonists become a treatment option for pediatric chronic immune thrombocytopenia in the future?
Gregory Cheng
Clinical Trail Perspective: Clinical Investigation
-
Will thrombopoietin receptor agonists become a treatment option for pediatric chronic immune thrombocytopenia in the future?
Gregory Cheng
Clinical Trail Perspective: Clinical Investigation
-
Will thrombopoietin receptor agonists become a treatment option for pediatric chronic immune thrombocytopenia in the future?
Gregory Cheng
Clinical Trail Perspective: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emergence of Neisseria meningitidis W-135 in the context of other rare serogroups
Luiz Jacintho da Silva, Lisa DeTora, Claudius Malerczyk & Ziad A Memish
Therapeutic Perspective: Clinical Investigation
-
Emergence of Neisseria meningitidis W-135 in the context of other rare serogroups
Luiz Jacintho da Silva, Lisa DeTora, Claudius Malerczyk & Ziad A Memish
Therapeutic Perspective: Clinical Investigation
-
Emergence of Neisseria meningitidis W-135 in the context of other rare serogroups
Luiz Jacintho da Silva, Lisa DeTora, Claudius Malerczyk & Ziad A Memish
Therapeutic Perspective: Clinical Investigation
-
Emergence of Neisseria meningitidis W-135 in the context of other rare serogroups
Luiz Jacintho da Silva, Lisa DeTora, Claudius Malerczyk & Ziad A Memish
Therapeutic Perspective: Clinical Investigation
-
Emergence of Neisseria meningitidis W-135 in the context of other rare serogroups
Luiz Jacintho da Silva, Lisa DeTora, Claudius Malerczyk & Ziad A Memish
Therapeutic Perspective: Clinical Investigation
-
Emergence of Neisseria meningitidis W-135 in the context of other rare serogroups
Luiz Jacintho da Silva, Lisa DeTora, Claudius Malerczyk & Ziad A Memish
Therapeutic Perspective: Clinical Investigation
-
Emergence of Neisseria meningitidis W-135 in the context of other rare serogroups
Luiz Jacintho da Silva, Lisa DeTora, Claudius Malerczyk & Ziad A Memish
Therapeutic Perspective: Clinical Investigation
-
Emergence of Neisseria meningitidis W-135 in the context of other rare serogroups
Luiz Jacintho da Silva, Lisa DeTora, Claudius Malerczyk & Ziad A Memish
Therapeutic Perspective: Clinical Investigation
-
Endocrine therapy for prostate cancer: review of the latest clinical evidence
Che-Kai Tsao, Sonia Seng, William K Oh Matthew D Galsky
Review Article: Clinical Investigation
-
Endocrine therapy for prostate cancer: review of the latest clinical evidence
Che-Kai Tsao, Sonia Seng, William K Oh Matthew D Galsky
Review Article: Clinical Investigation
-
Endocrine therapy for prostate cancer: review of the latest clinical evidence
Che-Kai Tsao, Sonia Seng, William K Oh Matthew D Galsky
Review Article: Clinical Investigation
-
Endocrine therapy for prostate cancer: review of the latest clinical evidence
Che-Kai Tsao, Sonia Seng, William K Oh Matthew D Galsky
Review Article: Clinical Investigation
-
Endocrine therapy for prostate cancer: review of the latest clinical evidence
Che-Kai Tsao, Sonia Seng, William K Oh Matthew D Galsky
Review Article: Clinical Investigation
-
Endocrine therapy for prostate cancer: review of the latest clinical evidence
Che-Kai Tsao, Sonia Seng, William K Oh Matthew D Galsky
Review Article: Clinical Investigation
-
Endocrine therapy for prostate cancer: review of the latest clinical evidence
Che-Kai Tsao, Sonia Seng, William K Oh Matthew D Galsky
Review Article: Clinical Investigation
-
Endocrine therapy for prostate cancer: review of the latest clinical evidence
Che-Kai Tsao, Sonia Seng, William K Oh Matthew D Galsky
Review Article: Clinical Investigation